Skip to content
Friday, May 20, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Aster DM flies higher with Skye Air drone partnership
  • WHO's scorecard shows global health achievements, despite COVID-19 pandemic
  • Pollution caused 1 in 6 deaths globally for five years, study says
  • Aenova invests US$11 mln to expand production of highly potent drugs in Germany
  • Takeda launches Adynovate, a hemophilia drug in India
  • Goldman Sachs expected to invest US$350mln in PharmEasy's parent company
  • Eight Roads launches US$250m fund for Indian healthcare firms
  • About 1 billion people globally denied access to assistive products: Report
  • Lilly’s blockbuster diabetes drug wins FDA approval
  • Global Fund unveils strategy to reduce deaths from AIDS, TB, and malaria
You are here
  • Home
  • Molnupiravir

Tag: Molnupiravir

Africa CDC partners Pfizer to supply antiviral COVID-19 pills

11 March 202211 March 2022

AFRICA – Africa Centres for Disease Control and Prevention (Africa CDC), a public health agency of the African Union, has partnered with pharmaceutical corporation Pfizer to supply the firm’s antiviral…

Read More

Generic manufacturers in developing countries licensed to make Merck’s COVID-19 pill

26 January 202220 March 2022

SWITZERLAND – The Medicines Patent Pool (MPP) has announced that it has signed contracts with 27 manufacturers to manufacture Merck’s COVID-19 pill. MPP’s agreements with generic manufacturers cover the production…

Read More

Omicron vaccine to be ready in March, says Pfizer CEO

12 January 202212 January 2022

USA – Pfizer CEO, Albert Bourla has said that the company expects a Covid-19 vaccine targeting the Omicron variant to be ready in March. Albert Bourla told CNBC that the…

Read More

Pfizer scores another Paxlovid deal with the US government

10 January 202210 January 2022

USA – The United States has increased its order for Pfizer’s COVID-19 antiviral Paxlovid from 10 million to 20 million courses, the company has announced. With two COVID-fighting antiviral pills…

Read More

Merck, Thermo Fisher in pact to manufacture oral COVID-19 pill in Canada

7 December 20217 December 2021

CANADA – Merck & Co has announced a deal with Thermo Fisher Scientific to manufacture its experimental COVID-19 pill at the medical device maker’s Whitby, Ontario facility, according to Reuters…

Read More

Pfizer plans to ramp up antiviral pill production in fight against Omicron variant

30 November 202130 November 2021

USA – Pfizer CEO, Albert Bourla has confirmed the company’s plans to increase production of its Paxlovid antiviral treatment in order to combat the spread of the new Omicron variant.…

Read More

Bayer, Dr. Reddy’s settle patent row over cancer drug Nexavar

22 November 202122 November 2021

GERMANY – Bayer Healthcare and Amgen subsidiary Onyx Pharmaceuticals have agreed to drop their patent lawsuit against Dr. Reddy’s Laboratories over the proposed generic version of Nexavar. According to a…

Read More

Pfizer, US ink US$ 5.29 billion deal for Covid pill

19 November 202119 November 2021

USA – Pfizer Inc has announced that the US government will pay US$5.29 billion for 10 million courses of its experimental COVID-19 antiviral drug, as the country seeks promising oral…

Read More

Pfizer applies for emergency use authorization of its novel COVID-19 pill

18 November 202118 November 2021

USA – Pfizer, a US-based pharmaceutical giant has asked the Food and Drug Administration to approve its experimental COVID-19 pill for emergency use, setting the stage for a likely launch…

Read More

Roche terminates partnership to develop COVID-19 pill with Atea

17 November 202117 November 2021

SWITZERLAND – Roche Holding AG has terminated its collaboration with Atea Pharmaceuticals Inc.to develop a COVID-19 antiviral pill, the Swiss drugmaker has announced. The partnership termination has happened a month…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Aster DM flies higher with Skye Air drone partnership

WHO’s scorecard shows global health achievements, despite COVID-19 pandemic

Pollution caused 1 in 6 deaths globally for five years, study says

Aenova invests US$11 mln to expand production of highly potent drugs in Germany

Takeda launches Adynovate, a hemophilia drug in India

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
Retweet on TwitterHealthCare Africa Magazine Retweeted
OliveMugendaProf. Olive Mugenda Ph.D MGH@OliveMugenda·
May 18, 2022

The Cath-Lab at KUTRRH is now ready for commissioning. Cath-Lab is a specialised lab that deals with diagnosing blockages within the heart, unblocking as well as performing other interventions like cardiac pacemaker placements.
A great milestone for KUTRRH, MoH and Kenyans.

4
Reply on Twitter 1526921388057051137Retweet on Twitter 152692138805705113726Like on Twitter 1526921388057051137111Twitter 1526921388057051137
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Regulatory approvals delay @CSL’s US$11.7 billion takeover of @ViforPharma
https://t.co/evoEdIx4d2 #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1526122199437934592Retweet on Twitter 1526122199437934592Like on Twitter 1526122199437934592Twitter 1526122199437934592
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

First simulated patient treatment performed in Hospital-based #BNCT Facility in #Europe
https://t.co/kMpazlYuAn #healthtech #innovation #health #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @CosylabHQ

Reply on Twitter 1526121369926258688Retweet on Twitter 1526121369926258688Like on Twitter 15261213699262586881Twitter 1526121369926258688
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

The @NIH warrants Covid-19 technologies to @WHO and @MedsPatentPool
https://t.co/XZQvOsU2Cx #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1526119119074082816Retweet on Twitter 1526119119074082816Like on Twitter 1526119119074082816Twitter 1526119119074082816
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.